Journal scan

Short reports on recently published research

Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir

Featured Latest news on the US crisis and its impact on global health

Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV

HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet

Combining injectable lenacapavir and cabotegravir-LA

Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs

Lancet Commission on gender justice and equality

Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care

People living with HIV need two shots of the mpox vaccine and likely a booster after two years

Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030